734 related articles for article (PubMed ID: 29101402)
1. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
Hedayati SS; Gregg LP; Carmody T; Jain N; Toups M; Rush AJ; Toto RD; Trivedi MH
JAMA; 2017 Nov; 318(19):1876-1890. PubMed ID: 29101402
[TBL] [Abstract][Full Text] [Related]
2. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial.
Jain N; Wan F; Kothari M; Adelodun A; Ware J; Sarode R; Hedayati SS
BMC Nephrol; 2019 Oct; 20(1):395. PubMed ID: 31664940
[TBL] [Abstract][Full Text] [Related]
3. Sertraline treatment of major depression in patients with acute MI or unstable angina.
Glassman AH; O'Connor CM; Califf RM; Swedberg K; Schwartz P; Bigger JT; Krishnan KR; van Zyl LT; Swenson JR; Finkel MS; Landau C; Shapiro PA; Pepine CJ; Mardekian J; Harrison WM; Barton D; Mclvor M;
JAMA; 2002 Aug; 288(6):701-9. PubMed ID: 12169073
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
[TBL] [Abstract][Full Text] [Related]
5. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial.
Friedli K; Guirguis A; Almond M; Day C; Chilcot J; Da Silva-Gane M; Davenport A; Fineberg NA; Spencer B; Wellsted D; Farrington K
Clin J Am Soc Nephrol; 2017 Feb; 12(2):280-286. PubMed ID: 28126706
[TBL] [Abstract][Full Text] [Related]
6. Depression and the Effect of Sertraline on Inflammatory Biomarkers in Patients with Nondialysis CKD.
Gregg LP; Carmody T; Le D; Bharadwaj N; Trivedi MH; Hedayati SS
Kidney360; 2020 Jun; 1(6):436-446. PubMed ID: 35368605
[TBL] [Abstract][Full Text] [Related]
7. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.
Lewis G; Duffy L; Ades A; Amos R; Araya R; Brabyn S; Button KS; Churchill R; Derrick C; Dowrick C; Gilbody S; Fawsitt C; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Khan N; Lanham P; Pervin J; Peters TJ; Riozzie D; Salaminios G; Thomas L; Welton NJ; Wiles N; Woodhouse R; Lewis G
Lancet Psychiatry; 2019 Nov; 6(11):903-914. PubMed ID: 31543474
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.
Wagner KD; Ambrosini P; Rynn M; Wohlberg C; Yang R; Greenbaum MS; Childress A; Donnelly C; Deas D;
JAMA; 2003 Aug; 290(8):1033-41. PubMed ID: 12941675
[TBL] [Abstract][Full Text] [Related]
9. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
Yonkers KA; Kornstein SG; Gueorguieva R; Merry B; Van Steenburgh K; Altemus M
JAMA Psychiatry; 2015 Oct; 72(10):1037-44. PubMed ID: 26351969
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM
JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145
[TBL] [Abstract][Full Text] [Related]
12. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial.
Brunoni AR; Valiengo L; Baccaro A; Zanão TA; de Oliveira JF; Goulart A; Boggio PS; Lotufo PA; Benseñor IM; Fregni F
JAMA Psychiatry; 2013 Apr; 70(4):383-91. PubMed ID: 23389323
[TBL] [Abstract][Full Text] [Related]
13. Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial.
Rolle CE; Fonzo GA; Wu W; Toll R; Jha MK; Cooper C; Chin-Fatt C; Pizzagalli DA; Trombello JM; Deckersbach T; Fava M; Weissman MM; Trivedi MH; Etkin A
JAMA Psychiatry; 2020 Apr; 77(4):397-408. PubMed ID: 31895437
[TBL] [Abstract][Full Text] [Related]
14. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
15. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic and psychological interventions for depression treatment in patients with kidney disease.
Gregg LP; Hedayati SS
Curr Opin Nephrol Hypertens; 2020 Sep; 29(5):457-464. PubMed ID: 32701597
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).
Jain N; Trivedi MH; Rush AJ; Carmody T; Kurian B; Toto RD; Sarode R; Hedayati SS
Contemp Clin Trials; 2013 Jan; 34(1):136-44. PubMed ID: 23085503
[TBL] [Abstract][Full Text] [Related]
18. Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial.
Flint AJ; Meyers BS; Rothschild AJ; Whyte EM; Alexopoulos GS; Rudorfer MV; Marino P; Banerjee S; Pollari CD; Wu Y; Voineskos AN; Mulsant BH;
JAMA; 2019 Aug; 322(7):622-631. PubMed ID: 31429896
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B
Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
